Articles
New crystalline structures may open door to molecular filters
Filtering different kinds of molecules has always been difficult, but a new process by researchers at the University of Rochester may have paved the way to creating a new kind of membrane with pores so fine they can separate a mixture of gases
[ + ]Quantitative evaluation of curved tablets using x-ray diffraction
Manufacturing processes of pharmaceutical tablets may change the morphology of the crystalline state of the active pharmaceutical ingredients (API) or the excipients
[ + ]FRET and FRET-FLIM microscopy imaging of localised protein interactions in living cell nucleus
FRET microscopy imaging is widely used to detect protein-protein interactions inside living cells. This application note describes the use of one and two-photon FRET and in characterising the dimerisation of C/EBPa protein
[ + ]SA Joins High-Performance Computing Fraternity
South Australia’s fledgling biotechnology industry has received the first of two shots in the arm with the commissioning of Hydra, a $1.7 million system that is Australia’s third-largest supercomputer and the largest of its type. [ + ]
Consuming passions
The consumables market in Australia has long been supported by the lab, mining and agricultural customer. But now, biotech is changing the landscape. Faster moving, smaller and more disposable, consumables are making the move to a technology based market. Jeremy Torr reports [ + ]
How M&A could raise biotech's living dead
Some Australian listed biotechs are trapped in a death spiral. Shareholders are reluctant to top up their original investments, while cash burn rates tip them ever closer to the edge of insolvency. But there are bright spots, writes Pete Young [ + ]
GM's lambs are inviting slaughter
Graeme O'Neill discovers that the biotech community needs a whole new strategy to win points on GM crops [ + ]
Reversing the flow of technology
La Trobe University physicists have reversed the traditional direction of technology flow by designing and building a highly sophisticated toroidal electron spectrometer and exporting it to Germany
[ + ]Using genomics in plant and animal selection
Following the launch of Genethon, France decided to invest heavily in investigating the genome of plants and, more recently, animals by means of high-budget programs combining public and private research. The first applications are now starting to appear
[ + ]Agbiotech's growing pains
Victoria prides itself as the powerhouse of Australian biotech. But not everything is blooming in the state's biotech garden, writes Graeme O'Neill [ + ]
Biomed, Victorian style: big science
Locals thank strong government support for helping to boost Victoria's biomedical industry, Melissa Trudinger discovers. [ + ]
Ernst & Young exec touts 'inevitable' biotech boom
There's at least one respected member of the investment community who believes the biotech boom is around the corner. Despite the complications that have surrounded the birth of the international biotechnology industry, Leslie Platt, a biotech investment expert with the international accountancy firm Ernst and Young, is irrepressibly bullish about its future. [ + ]
Proteomics at your service
The service centre model for proteomics has taken off in the last few years. Iain Scott looks at some of the groups around Australia who are staking out their claims in this area. [ + ]
Building on the foundations
Other states may have more surface glitz and glamour, but many local experts agree NSW has the makings of a solid, healthy and expanding biotech industry. Jeremy Torr investigates. [ + ]
New potential unleashed for microarrays
With the 3rd Australian Microarray Conference just around the corner, Jeremy Torr takes a look at what's new in the technology. [ + ]
